Publicacións (73) Publicacións de Juan Fernández Tajes Ver datos de investigación referenciados.

2024

  1. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

    Frontiers in Pharmacology, Vol. 15

  2. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

    Nature Communications, Vol. 15, Núm. 1

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes

    Nature Metabolism, Vol. 5, Núm. 2, pp. 237-247

  3. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

    Nature Genetics

  4. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

    Nature Genetics, Vol. 55, Núm. 1, pp. 89-99

  5. Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

    Nature Communications, Vol. 14, Núm. 1

  6. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

    The Lancet Diabetes and Endocrinology, Vol. 11, Núm. 1, pp. 33-41

2022

  1. Impact of insufficient sleep on dysregulated blood glucose control under standardised meal conditions

    Diabetologia, Vol. 65, Núm. 2, pp. 356-365

2021

  1. A prospective study of the relationships between movement and glycemic control during day and night in pregnancy

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. A Multi-omic Integrative Scheme Characterizes Tissues of Action at Loci Associated with Type 2 Diabetes

    American Journal of Human Genetics, Vol. 107, Núm. 6, pp. 1011-1028

  2. A reference map of potential determinants for the human serum metabolome

    Nature, Vol. 588, Núm. 7836, pp. 135-140

  3. Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis

    GeroScience, Vol. 42, Núm. 6, pp. 1451-1473

  4. Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study

    EBioMedicine, Vol. 58

  5. Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus

    Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 6, pp. E002769

  6. Low vitamin d levels and frailty status in older adults: A systematic review and meta-analysis

    Nutrients, Vol. 12, Núm. 8, pp. 1-20

  7. Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts

    PLoS Medicine, Vol. 17, Núm. 6

2019

  1. Association analyses identify 31 new risk loci for colorectal cancer susceptibility

    Nature Communications, Vol. 10, Núm. 1

  2. Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria (PLoS Genet (2018) 14:12 (e1007813) DOI: )10.1371/journal.pgen.1007813

    PLoS Genetics

  3. Developing a network view of type 2 diabetes risk pathways through integration of genetic, genomic and functional data

    Genome Medicine, Vol. 11, Núm. 1